Mechanistic insights into cardiovascular protection for omega-3 fatty acids and their bioactive lipid metabolites.
Eicosapentaenoic acid inhibits membrane lipid oxidation in a concentration-dependent manner at pharmacologic doses in vitro
Eicosapentaenoic acid (EPA) has optimal chain length and degree of unsaturation to inhibit oxidation of small dense LDL and membrane cholesterol domains as compared to related fatty acids in vitro.
Eicosapentaenoic acid inhibits membrane cholesterol domains compared to other omega-3 fatty acids under conditions of hyperglycemia [abstract 005].
Eicosapentaenoic acid (EPA) containing phospholipids modulate membrane structure.